In last trading session, Petros Pharmaceuticals Inc (NASDAQ:PTPI) saw 34.3 million shares changing hands with its beta currently measuring 1.93. Company’s recent per share price level of $0.14 trading at $0.01 or 10.41% at ring of the bell on the day assigns it a market valuation of $0.30M. That closing price of PTPI’s stock is at a discount of -12757.14% from its 52-week high price of $18.00 and is indicating a premium of 28.57% from its 52-week low price of $0.10. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 17.45 million shares which gives us an average trading volume of 4.68 million if we extend that period to 3-months.

Petros Pharmaceuticals Inc (NASDAQ:PTPI) trade information

Upright in the green during last session for gaining 10.41%, in the last five days PTPI remained trading in the red while hitting it’s week-highest on Friday, 05/09/25 when the stock touched $0.14 price level, adding 33.33% to its value on the day. Petros Pharmaceuticals Inc’s shares saw a change of -98.58% in year-to-date performance and have moved -5.28% in past 5-day. Petros Pharmaceuticals Inc (NASDAQ:PTPI) showed a performance of -87.83% in past 30-days. Number of shares sold short was 0.49 million shares which calculate 0.17 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 55.46% during past 5 years.

Petros Pharmaceuticals Inc (NASDAQ:PTPI)’s Major holders

Insiders are in possession of 7.39% of company’s total shares while institution are holding 5.36 percent of that, with stock having share float percentage of 5.79%. Investors also watch the number of corporate investors in a company very closely, which is 5.36% institutions for Petros Pharmaceuticals Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 3.67 shares of worth $514.0 or 0.17% of the total outstanding shares. The later fund manager was in possession of 1.27 shares on Dec 31, 2024 , making its stake of worth around $178.0 in the company or a holder of 0.06% of company’s stock.